TYK Medicines Funding: $154M Raised, Series D (2023)
TYK Medicines is based in Huzhou, China. It has raised $154M in total funding. Latest round: Series D.
TYK Medicines funding overview
TYK Medicines is based in Huzhou, China. TYK Medicines has raised $154M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series D announced in December 2023. The round record for TYK Medicines runs through 2023; nothing later has been disclosed. Investors on record include Sichuan Huiyu Pharmaceutical, Yida China Holdings, Guohai Innovation Capital Investment Management. 3 distinct backers are named across the disclosed rounds.
TYK Medicines at a glance
Total raised
$154M
Latest round
Series D
Latest round date
December 2023
Headquarters
Huzhou, China
Notable investors
Sichuan Huiyu Pharmaceutical, Yida China Holdings, Guohai Innovation Capital Investment Management
Frequently asked about TYK Medicines funding
How much has TYK Medicines raised?
TYK Medicines has raised $154M in total disclosed funding across the rounds on record.
Who has invested in TYK Medicines?
Sichuan Huiyu Pharmaceutical, Yida China Holdings, Guohai Innovation Capital Investment Management are named among the investors backing TYK Medicines.
What was the latest TYK Medicines funding round?
The most recent disclosed round is a Series D, announced in December 2023.
Where is TYK Medicines based?
TYK Medicines is based in Huzhou, China.
When did TYK Medicines last raise?
The last disclosed TYK Medicines round closed in December 2023 at Series D.
TYK Medicines totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Huzhou below to benchmark round size and investor mix.
